Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial by Gabay, Cem, MD, Emery, Paul, MD, van Vollenhoven, Ronald, MD, Dikranian, Ara, MD, Alten, Rieke, MD, Pavelka, Karel, MD, Klearman, Micki, MD, Musselman, David, MD, Agarwal, Sunil, MD, Green, Jennifer, MSc, Kavanaugh, Arthur, Dr

Get full text

Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised con... by Smolen, Josef S, Prof, Emery, Paul, Prof, Fleischmann, Roy, Prof, van Vollenhoven, Ronald F, Prof, Pavelka, Karel, Prof, Durez, Patrick, Prof, Guérette, Benoît, PhD, Kupper, Hartmut, MD, Redden, Laura, MD, Arora, Vipin, PhD, Kavanaugh, Arthur, Prof

Get full text

Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised control... by Smolen, Josef S, Prof, Nash, Peter, MD, Durez, Patrick, Prof, Hall, Stephen, MD, Ilivanova, Elena, MD, Irazoque-Palazuelos, Fedra, MD, Miranda, Pedro, MD, Park, Min-Chan, MD, Pavelka, Karel, Prof, Pedersen, Ronald, MS, Szumski, Annette, MS, Hammond, Constance, BS, Koenig, Andrew S, DO, Vlahos, Bonnie, BSN

Get full text